Industries:
Biotechnology
Life Science
Pharmaceutical
Biopharma
Health Care
Medical
Therapeutics
Association
Education
Genetics
Investor Types:
Venture Capital
Investment Stages:
Location: London, England, United Kingdom
Syncona is a leading healthcare company focused on investing in and building global leaders in life science. Their vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
They seek to partner with the best, brightest and most ambitious minds in science
to build globally competitive businesses. They take a long-term view, underpinned by a deep pool of capital, and are established leaders in the development of genetic medicine, particularly gene and cell therapy. They focus on delivering dramatic efficacy for patients in areas of high unmet need.
Syncona is aligned with two of the premium charitable funders in UK science, The Wellcome Trust, original founder of Syncona, and Cancer Research UK, both of which are significant shareholders in their business. They make a donation of 0.3% of Net Asset Value to a range of charities each year.